-
ASSOCIATION OF FATIGUE AND ACUTE PAIN WITH HEALTH CARE RESOURCE UTILIZATION AND COSTS IN SICKLE CELL DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF INCIDENT BRAIN METASTASES IN MEDICARE BENEFICIARIES WITH ALK+ METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
COMBINING DISCRETE CHOICE EXPERIMENT AND CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINE ATTRIBUTES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
DISTINGUISHING AI FROM AUTOMATION IN HEOR: LESSONS FROM OTHER INDUSTRIES
Mar 18, 2026, 21:38 PM -
BRIDGING HER2 TESTING AND TREATMENT: REAL-WORLD EVIDENCE ACROSS 22 SOLID TUMORS
Mar 18, 2026, 21:38 PM -
NEUROLOGIST PREFERENCES FOR NEW MS TREATMENTS: IMPLICATIONS FOR MARKET ACCESS PRIORITIZATION IN THE UNITED STATES AND EUROPE
Mar 18, 2026, 21:38 PM -
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Mar 18, 2026, 21:38 PM -
DISEASE PERCEPTION, QUALITY OF LIFE, AND MENTAL HEALTH OF NEWLY DIAGNOSED AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)-ELIGIBLE MULTIPLE MYELOMA PATIENTS FROM A TERTIARY CARE HOSPITAL IN CHINA: A CROSS-SECTIONAL SURVEY STUDY
Mar 18, 2026, 21:38 PM -
CHARACTERIZING REAL-WORLD DISEASE BURDENS IN CARDIAC AMYLOIDOSIS: A DESCRIPTIVE STUDY ON SOCIAL, ECONOMIC, AND ACCESS-RELATED IMPACTS ON PATIENTS IN GERMANY AND SPAIN
Mar 18, 2026, 21:38 PM -
A QUALITATIVE STUDY TO EXPLORE PATIENT PERSPECTIVES ON FUTURE GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) SARCOGLYCANOPATHY SUBTYPES 2E/R4, 2D/R3, AND 2C/R5
Mar 18, 2026, 21:38 PM -
TRANSLATION AND PSYCHOMETRIC EVALUATION OF THE YORUBA VERSION OF IBADAN LOW-BACK PAIN DISABILITY QUESTIONNAIRE
Mar 18, 2026, 21:38 PM -
CONSENSUS ON BARRIERS AND UNMET NEEDS IN HEMOPHILIA CARE IN BRAZIL: A MODIFIED DELPHI STUDY
Mar 18, 2026, 21:38 PM -
ECONOMIC VALUE OF RSV MATERNAL VACCINATION TO PREVENT INFANT DISEASE IN ECUADOR
Mar 18, 2026, 21:38 PM -
GLOBAL REGULATORY ASYMMETRIES AND THE STRUCTURAL DRUG LAG: TIME TO MARKET AUTHORIZATION IN CÔTE D’IVOIRE
Mar 18, 2026, 21:38 PM -
DOES ARTIFICIAL INTELLIGENCE IMPROVE OUTCOMES IN ACUTE ISCHEMIC STROKE CARE?
Mar 18, 2026, 21:38 PM -
HARNESSING AGENTIC AI FOR COHORT IDENTIFICATION: A CASE STUDY IN CLL/SLL PATIENTS TREATED WITH BTK INHIBITORS AT A US ACADEMIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
META-ANALYSIS OF QUALITY OF LIFE AMONG PATIENTS WITH HEPATITIS C WITH OR WITHOUT SUSTAINED VIROLOGICAL RESPONSE
Mar 18, 2026, 21:38 PM -
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Mar 18, 2026, 21:38 PM -
ESTIMATING THE FINANCIAL IMPACT OF DUPILUMAB FOR COPD USING REAL-WORLD CLAIMS DATA: A PROBABILISTIC BUDGET IMPACT ANALYSIS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
FROM PROMPT ENGINEERING TO DECISION-MAKING: ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM
